What is the next step in managing a patient with hypercortisolism and an adrenocorticotropic hormone (ACTH) level of 16 that is not suppressed?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 5, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Hypercortisolism with Non-Suppressed ACTH Level of 16

For a patient with confirmed hypercortisolism and a non-suppressed ACTH level of 16, the next step should be bilateral inferior petrosal sinus sampling (BIPSS) to differentiate between pituitary Cushing's disease and ectopic ACTH syndrome. 1

Diagnostic Algorithm for ACTH-Dependent Hypercortisolism

Interpretation of ACTH Level

  • An ACTH level of 16 confirms ACTH-dependent Cushing's syndrome, as ACTH is detectable (>5 ng/l or >1.1 pmol/l) 1
  • In ACTH-independent Cushing's syndrome (adrenal causes), ACTH would be low or undetectable due to negative feedback inhibition 2
  • A detectable ACTH level indicates either pituitary Cushing's disease or ectopic ACTH production 1

Imaging Studies

  • Pituitary MRI should be performed to look for adenoma 1
  • However, approximately one-third of pituitary MRI scans in Cushing's disease patients remain negative despite the presence of disease 1
  • If MRI shows a definite pituitary adenoma that is unlikely to be an incidentaloma, this may be sufficient for diagnosis 1

Confirmatory Testing

  • BIPSS is the gold standard for differentiating between pituitary and ectopic sources of ACTH 1
  • BIPSS should be performed especially when:
    • MRI findings are negative or equivocal 1
    • Clinical, biochemical, or radiological studies are discordant 3
    • There is suspicion of ectopic ACTH syndrome despite normal imaging 4

BIPSS Procedure and Interpretation

  • BIPSS should only be performed at specialized centers with experienced interventional radiologists 1
  • During BIPSS, a pituitary source of ACTH is confirmed by:
    • ≥2:1 ratio of central-to-peripheral ACTH before CRH or desmopressin stimulation 1
    • ≥3:1 ratio after CRH or desmopressin stimulation 1
  • BIPSS may also provide information on tumor lateralization if the inter-petrosal sinus ACTH gradient after stimulation is ≥1.4 between the two sides 1
  • Hypercortisolemia should be confirmed immediately prior to BIPSS to ensure active disease phase, especially in cyclical Cushing's disease 1

Important Considerations

  • Medical therapy for hypercortisolism (steroidogenesis inhibitors) must be stopped before BIPSS to ensure accurate interpretation 1
  • If BIPSS confirms Cushing's disease, surgical resection of the pituitary adenoma is the optimal treatment 5
  • If BIPSS suggests ectopic ACTH syndrome, additional imaging (CT chest/abdomen) should be performed to locate the source 6, 7
  • Untreated hypercortisolism can lead to significant morbidity and mortality, including severe infections, clotting disorders, and metabolic complications 1

Treatment Considerations

  • Surgical resection of the tumor (pituitary or ectopic source) is the optimal treatment for all forms of Cushing's syndrome 5
  • If surgery is not immediately possible or effective, medical therapy with steroidogenesis inhibitors like ketoconazole may be considered 2, 5
  • Pasireotide may be considered for Cushing's disease patients, with monitoring for hyperglycemia and QT prolongation 8
  • Bilateral adrenalectomy may be necessary in cases where the source cannot be identified or controlled 4

BIPSS is crucial for accurate diagnosis and appropriate management of ACTH-dependent Cushing's syndrome, as it will guide the surgical approach and overall treatment strategy, ultimately improving morbidity, mortality, and quality of life outcomes.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

ACTH-Independent Hypercortisolism

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Approach to the patient with possible Cushing's syndrome.

The Journal of clinical endocrinology and metabolism, 2009

Research

Evaluation and treatment of Cushing's syndrome.

The American journal of medicine, 2005

Research

Diagnostic approach to Cushing disease.

Neurosurgical focus, 2007

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.